Inhibition of obesity-induced hepatic er stress by early insulin therapy in obese diabetic rats

Endocrine

Volumn 39, Issue 3, 2011, Pages 235-241

  Sun, Weiping ^a   Bi, Yan ^a   Liang, Hua ^a   Cai, Mengyin ^a   Chen, Xiang ^a   Zhu, Yanhua ^a   Li, Ming ^a   Xu, Fen ^a   Yu, Qiuqiong ^a   He, Xiaoying ^a   Ye, Jianping ^b   Weng, Jianping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Endoplasmic reticulum stress; Insulin; Insulin sensitivity; Steatosis; Sterol regulatory element binding proteins; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE 6 PHOSPHATASE; IMMUNOGLOBULIN BINDING PROTEIN; INOSITOL REQUIRING PROTEIN 1 ALPHA; INSULIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN KINASE B; SERINE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; GENE; GENE EXPRESSION REGULATION; GLUCOSE 6 PHOSPHATASE GENE; INSULIN SENSITIVITY; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STREPTOZOCIN DIABETES; UPREGULATION;

EID: 79960020593     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9429-y     Document Type: Article

References (42)

1. J. Weng, Y. Li, W. Xu et al., Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 371, 1753-1760(2008) (Pubitemid 351697950)
2. Y. Bi, W. P. Sun, X. Chen et al., Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats. Acta Diabetol 45, 167-178(2008)
3. Y. Li, W. Xu, Z. Liao et al., Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 27, 2597-2602(2004) (Pubitemid 39441457)
4. M. J. Gormley, D. R. Hadden, R. Woods et al., One month's insulin treatment of type II diabetes: the early and medium-term effects following insulin withdrawal. Metabolism 35, 1029-1036(1986) (Pubitemid 17186305)
5. W. J. Andrews, B. Vasquez, M. Nagulesparan et al., Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes 33, 634-642(1984) (Pubitemid 14087554)
6. W. T. Garvey, J. M. Olefsky, J. Griffin et al., The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34, 222-234(1985) (Pubitemid 15134779)
7. M. Laakso, M. Uusitupa, J. Takala et al., Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects. Metabolism 37, 1092-1100(1988)
8. M. C. Bravi, A. Armiento, O. Laurenti et al., Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus. Metabolism 55, 691-695(2006) (Pubitemid 44316511)
9. H. Kaneto, Y. Nakatani, D. Kawamori et al., Role of oxidative stress, endoplasmic reticulum stress, and c-Jun. N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. Int. J. Biochem. Cell Biol. 37, 1595-1608(2005) (Pubitemid 40719639)
10. L. Juurinen, M. Tiikkainen, A. M. Hakkinen et al., Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292, E829-E835 (2007) (Pubitemid 46411061)
11. D. LeRoith, V. Fonseca, Vinik A Metabolic memory in diabetes-focus on insulin. Diabetes Metab. Res. Rev. 21, 85-90(2005) (Pubitemid 40467657)
12. U. Ozcan, Q. Cao, E. Yilmaz et al., Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461(2004) (Pubitemid 39372439)
13. A. Garg, A. Misra, Hepatic steatosis, insulin resistance, and adipose tissue disorders. J. Clin. Endocrinol. Metab. 87, 3019-3022(2002) (Pubitemid 34816337)
14. A. Seppala-Lindroos, S. Vehkavaara, A. M. Hakkinen et al., Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87, 3023-3028(2002) (Pubitemid 34816338)
15. Y. Bi, M. Cai, H. Liang et al., Increased carnitine palmitoyl transferase 1 expression and decreased sterol regulatory elementbinding protein 1c expression are associated with reduced intramuscular triglyceride accumulation after insulin therapy in highfat-diet and streptozotocin-induced diabetic rats. Metabolism 58, 779-786(2009)
16. M. J. Reed, K. Meszaros, L. J. Entes et al., A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49, 1390-1394(2000)
17. K. Srinivasan, B. Viswanad, L. Asrat et al., Combination of highfat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52, 313-320(2005) (Pubitemid 41175991)
18. M. Sugano, H. Yamato, T. Hayashi et al., High-fat diet in lowdose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy. Nutr. Metab. Cardiovasc. Dis. 16, 477-484(2006) (Pubitemid 44466387)
19. K. Sahin, M. Onderci, M. Tuzcu et al., Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism 56, 1233-1240(2007) (Pubitemid 47225177)
20. J. E. Pessin, A. R. Saltiel, Signaling pathways in insulin action: molecular targets of insulin resistance. J. Clin. Invest. 106, 165-169(2000) (Pubitemid 30483117)
21. R. W. Hanson, L. Reshef, Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem. 66, 581-611(1997) (Pubitemid 27274668)
22. J. Hirosumi, G. Tuncman, L. Chang et al., A central role for JNK in obesity and insulin resistance. Nature 420, 333-336(2002) (Pubitemid 35398190)
23. A. S. Lee, The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 35, 373-381(2005) (Pubitemid 40445371)
24. J. D. Horton, J. L. Goldstein, M. S. Brown, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131(2002) (Pubitemid 34496588)
25. G. Boden, X. Duan, C. Homko et al., Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 57, 2438-2444(2008)
26. M. S. Brown, J. L. Goldstein, A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. USA 96, 11041-11048(1999) (Pubitemid 29487324)
27. M. S. Brown, J. L. Goldstein, The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331-340(1997) (Pubitemid 27220877)
28. M. S. Brown, J. Ye, R. B. Rawson et al., Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391-398(2000)
29. H. L. Kammoun, H. Chabanon, I. Hainault et al., GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119, 1201-1215(2009)
30. T. Pratipanawatr, K. Cusi, P. Ngo et al., Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes. Diabetes 51, 462-468(2002) (Pubitemid 34764804)
31. S. Matthaei, M. Stumvoll, M. Kellerer et al., Pathophysiology and pharmacological treatment of insulin resistance. Endocr. Rev. 21, 585-618(2000) (Pubitemid 32113286)
32. U. Ozcan, E. Yilmaz, L. Ozcan et al., Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137-1140(2006) (Pubitemid 44300242)
33. S. K. Das, W. S. Chu, A. K. Mondal et al., Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines. Am. J. Physiol. Endocrinol. Metab. 295, E393-E400 (2008)
34. N. K. Sharma, S. K. Das, A. K. Mondal et al., Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. J. Clin. Endocrinol. Metab. 93, 4532-4541(2008) (Pubitemid 352789557)
35. G. J. Hausman, Richardson RL Adipose tissue angiogenesis. J. Anim. Sci. 82, 925-934(2004)
36. Y. Cao, Angiogenesis modulates adipogenesis and obesity. J. Clin. Invest. 117, 2362-2368(2007) (Pubitemid 47494333)
37. J. Ye, Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int. J. Obes. (Lond) 33, 54-66(2009)
38. J. Ye, Z. Gao, J. Yin et al., Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 293, E1118-E1128 (2007) (Pubitemid 47535846)
39. J. Yin, Z. Gao, Q. He et al., Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 296, E333-E342 (2009)
40. C. Pang, Z. Gao, J. Yin et al., Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am. J. Physiol. Endocrinol. Metab. 295, E313-E322 (2008)
41. H. Shimano, N. Yahagi, M. Amemiya-Kudo et al., Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J. Biol. Chem. 274, 35832-35839(1999) (Pubitemid 129512888)
42. M. Foretz, C. Guichard, P. Ferre et al., Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. USA 96, 12737-12742(1999) (Pubitemid 29513572)